Clinical Trial Update: Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a diabetes vaccine in newly diagnosed diabetics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus

Drugs mentioned

• Diabetes vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Insulin-dependent Diabetes Mellitus, Diabetes Mellitus | Phase 1 | Status: COMPLETED